Budapest, April 13, 2011 (MTI-ECONEWS) – The University of Debrecen (E Hungary) and the Hungarian Academy of Sciences Biology Centre in Szeged (SE Hungary) could patent new chemical compounds for the treatment of diabetes as the result of a HUF 500m research project, Debrecen University Chemistry Department chairman Tamas Patonay told MTI.
The 20-member research group started the project to develop active ingredients for type 2 diabetes medicines that have fewer side effects in the summer of 2009, Mr Patonay said. Thus far, three compounds have shown positive results in laboratory mice, and a fourth compound is currently being tested, he added.
The consortium wants to patent at least one compound, but perhaps more, when the project winds up in the summer, he said.
The researchers, including four from abroad, won a HUF 425m European Union grant for the project. Self-financing and support from drugmakers covered the remaining HUF 75m cost.
(HUF 100 = EUR 0.3756)